[144] Workday, Inc. SEC Filing

Rhea-AI Filing Summary

Workday, Inc. insider notice reports a proposed sale of 75,053 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value listed as $17,500,108.01. The shares were acquired in a private placement on 12/27/2007 and payment was in cash. The filing lists the total number of shares outstanding as 217,000,000 and an approximate sale date of 10/08/2025.

The form also discloses multiple prior Rule 10b5-1 sales by related trusts and a foundation in September and October 2025, showing individual sale amounts and gross proceeds. The signer affirms no undisclosed material adverse information and references the 10b5-1 plan representation language required by the notice.

Positive

• Proposed sale routed through a major broker (Morgan Stanley Smith Barney LLC)
• Sale paperwork includes acquisition detail showing purchase in a private placement on 12/27/2007
• Multiple prior entries are explicitly labeled as 10b5-1 sales, indicating pre-arranged plans

Negative

• Several insider sales occurred in September and October 2025, showing ongoing disposition of shares
• The filing notifies a sale with an aggregate market value of $17,500,108.01, which increases available shares for market trading

Insights

Insider Transactions Analyst

Insider intends a registered sale of $17.5M of common stock via an established broker.

The filing shows a planned brokered sale of 75,053 shares on 10/08/2025, acquired in a private placement on 12/27/2007. The transaction is being processed through Morgan Stanley Smith Barney LLC and is reported under Rule 144.

Related entries list multiple prior 10b5-1 sales in September and October 2025, indicating an active, pre‑arranged selling program. Watch for completed trade reports around the stated date to confirm execution and any short‑term effect on available float.

Securities Compliance Specialist

Filing is a routine Rule 144 notice with 10b5-1 sale history and required seller attestations.

The document discloses acquisition details, payment method, and an attestation that no undisclosed material adverse information exists. Several prior sales are explicitly labeled as 10b5-1, meeting the standard disclosure pattern for pre‑arranged insider sales.

Key compliance items to note are the plan adoption/notice dates and broker routing; confirmation filings and Form 4s should be reviewed to verify consistency with these entries within the normal reporting window.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	75053	17500108.01	217000000	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2007	Private Placement	Issuer			75053	12/27/2007	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	10/01/2025	72696	17090277.11
10b5-1 Sales for THE DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	09/23/2025	72118	17421401.02
10b5-1 Sales for THE DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	09/16/2025	78564	17293601.96
10b5-1 Sales for The Dave & Cheryl Duffield Foundation 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	09/15/2025	15000	3333516.00
10b5-1 Sales for THE DAVID A DUFFIELD TRUST U/T/A 7/14/88 6110 Stoneridge Mall Road Pleasanton CA 94588	Common	09/02/2025	75817	17298270.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Workday's (WDAY) Form 144 disclose about the proposed sale?

It discloses a proposed sale of 75,053 common shares via Morgan Stanley Smith Barney LLC on 10/08/2025 with an aggregate market value of $17,500,108.01.

When were the shares being sold originally acquired?

The shares were acquired in a private placement on 12/27/2007, and payment was in cash.

Does the filing show any prior related sales?

Yes; the filing lists multiple Rule 10b5-1 sales in September and October 2025 by related trusts and a foundation, with specific amounts and gross proceeds for each trade.

How many Workday shares are outstanding according to the form?

The filing reports 217,000,000 shares outstanding.

What attestation does the seller make in the Form 144?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references reliance on any adopted 10b5-1 trading plan where applicable.